{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:19:53Z","timestamp":1791839993440,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T00:00:00Z","timestamp":1589241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007771","name":"\u015al\u0105ski Uniwersytet Medyczny","doi-asserted-by":"publisher","award":["KNW-1-158\/N\/9\/K"],"award-info":[{"award-number":["KNW-1-158\/N\/9\/K"]}],"id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Localized Scleroderma (LoS) is an autoimmune connective tissue disease that affects skin and less commonly subcutaneous tissues. The illness occurs in children and adults, and may have a serious impact on health-related quality of life (HRQoL). The goal of this study was to explore what factors might deteriorate scores on HRQoL measures in adult LoS patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Detailed information on the demographic and clinical features of LoS patients was collected. The HRQoL was assessed using Skindex-29 and Short form 36 (SF-36) questionnaires.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty three women and seven men with LoS were enrolled. Female gender negatively influenced scores for the emotion subscale of Skindex-29. Multiple-factor linear regression analysis confirmed, as with single-factor analysis, that the causes of low SF-36 physical component score (PCS) were subjective symptoms (pruritus, pain, paresthesia), musculoskeletal manifestations and older age at the time of survey, while rural area of residence negatively affected the SF-36 mental component score. Additionally, single-factor analysis showed that the SF-36 PCS was related to the LoS cutaneous assessment tool (LoSCAT) summary score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Apart from a clinical presentations, sociodemographic characteristics, including older age, female gender and living conditions, may impair HRQoL of LoS patients. Further studies that will examine the role of these factors for physical and mental functioning of adults with LoS are needed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12955-020-01386-0","type":"journal-article","created":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T07:03:07Z","timestamp":1589266987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Health-related quality of life and its influencing factors in adult patients with localized scleroderma - a cross-sectional study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-7710","authenticated-orcid":false,"given":"Anna","family":"Lis-\u015awi\u0119ty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Skrzypek-Salamon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irmina","family":"Ranosz-Janicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ligia","family":"Brzezi\u0144ska-Wcis\u0142o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,12]]},"reference":[{"issue":"10","key":"1386_CR1","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1111\/jdv.14197","volume":"31","author":"A Lis-\u015awi\u0119ty","year":"2017","unstructured":"Lis-\u015awi\u0119ty A, Skrzypek-Salamon A, Ranosz-Janicka I, Brzezi\u0144ska-Wcis\u0142o L. Localized scleroderma: clinical and epidemiological features with emphasis on adulthood- versus childhood-onset disease differences. J Eur Acad Dermatol Venereol. 2017;31(10):1595\u2013603.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1386_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.5114\/dr.2019.88252","volume":"106","author":"D Krasowska","year":"2019","unstructured":"Krasowska D, Rudnicka L, Da\u0144czak-Pazdrowska A, Chodorowska G, Wo\u017aniacka A, Lis-\u015awi\u0119ty A, et al. Localized scleroderma (morphea). Diagnostic and therapeutic recommendations of the polish dermatological society. Dermatol Rev Przegl\u0105d Dermatologiczny. 2019;106(4):333\u201353.","journal-title":"Dermatol Rev Przegl\u0105d Dermatologiczny"},{"issue":"9","key":"1386_CR3","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1080\/00207454.2016.1244823","volume":"127","author":"A Lis-\u015awi\u0119ty","year":"2017","unstructured":"Lis-\u015awi\u0119ty A, Brzezi\u0144ska-Wcis\u0142o L, Arasiewicz H. Neurological abnormalities in localized scleroderma of the face and head: a case series study for evaluation of imaging findings and clinical course. Int J Neurosci. 2017;127(9):835\u20139.","journal-title":"Int J Neurosci"},{"issue":"5","key":"1386_CR4","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2013.11.037","volume":"70","author":"S Das","year":"2014","unstructured":"Das S, Bernstein I, Jacobe H. Correlates of selfreported quality of life in adults and children with morphea. J Am Acad Dermatol. 2014;70(5):904\u201310.","journal-title":"J Am Acad Dermatol"},{"key":"1386_CR5","doi-asserted-by":"crossref","unstructured":"Klimas, N. K., Shedd, A. D., Bernstein, I. H., & Jacobe, H. (2015). Health-related quality of life in morphoea. British J Dermatol, 172(5), 1329\u20131337. 12.","DOI":"10.1111\/bjd.13572"},{"issue":"9","key":"1386_CR6","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1001\/archdermatol.2009.202","volume":"145","author":"EB Kroft","year":"2009","unstructured":"Kroft EB, de Jong EM, Evers AW. Psychological distress in patients with morphea and eosinophilic fasciitis. Arch Dermatol. 2009;145(9):1017\u20131022. 13.","journal-title":"Arch Dermatol"},{"issue":"10","key":"1386_CR7","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1001\/archderm.144.10.1394","volume":"144","author":"EB Kroft","year":"2008","unstructured":"Kroft EB, de Jong EM, Evers AW. Physical burden of symptoms in patients with localized scleroderma and eosinophilic fasciitis. Arch Dermatol. 2008;144(10):1394\u20131395. 14.","journal-title":"Arch Dermatol"},{"issue":"4","key":"1386_CR8","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s11482-013-9273-3","volume":"9","author":"B Szramka-Pawlak","year":"2014","unstructured":"Szramka-Pawlak B, Danczak-Pazdrowska A, Rzepa T, Szewczyk A, Sadowska-Przytocka A, Zaba R. Quality of life and optimism in patients with morphea. Appl Res Qual Life. 2014;9(4):863\u2013870. 15.","journal-title":"Appl Res Qual Life"},{"issue":"6","key":"1386_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1080\/13548506.2013.764461","volume":"18","author":"B Szramka-Pawlak","year":"2013","unstructured":"Szramka-Pawlak B, Danczak-Pazdrowska A, Rzepa T, Szewczyk A, Sadowska-Przytocka A, Zaba R. Healthrelated quality of life, optimism, and coping strategies in persons suffering from localized scleroderma. Psychol Health Med. 2013;18(6):654\u201363.","journal-title":"Psychol Health Med"},{"issue":"10","key":"1386_CR10","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s11136-018-1897-1","volume":"27","author":"G Bali","year":"2018","unstructured":"Bali G, K\u00e1rp\u00e1ti S, S\u00e1rdy M, Brodszky V, Hidv\u00e9gi B, Rencz F. Association between quality of life and clinical characteristics in patients with morphea. Qual Life Res. 2018;27(10):2525\u201332. https:\/\/doi.org\/10.1007\/s11136-018-1897-1 Epub 2018 Jun 19.","journal-title":"Qual Life Res"},{"issue":"9","key":"1386_CR11","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archdermatol.2010.239","volume":"146","author":"S Saxton-Daniels","year":"2010","unstructured":"Saxton-Daniels S, Jacobe HT. An evaluation of long-term outcomes in adults with pediatric-onset morphea. Arch Dermatol. 2010;146(9):1044\u20135.","journal-title":"Arch Dermatol"},{"issue":"2","key":"1386_CR12","first-page":"429","volume":"18","author":"P Zagozdzon","year":"2011","unstructured":"Zagozdzon P, Kolarzyk E, Marcinkowski JT. Quality of life and rural place of residence in polish women - population based study. Ann Agric Environ Med. 2011;18(2):429\u201332.","journal-title":"Ann Agric Environ Med"},{"key":"1386_CR13","doi-asserted-by":"publisher","unstructured":"\u0106wirlej-Soza\u0144ska, A.B,. Soza\u0144ski, B., Wi\u015bniowska-Szurlej, A., Wilmowska-Pietruszy\u0144ska, A. (2018). Quality of life and related factors among older people living in rural areas in South-Eastern Poland. Ann Agric Environ Med, 25(3), 539-545. Doi: https:\/\/doi.org\/10.26444\/aaem\/93847. Epub 2018 Sep 18.","DOI":"10.26444\/aaem\/93847"},{"issue":"2","key":"1386_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/ddg.12724","volume":"14","author":"A Kreuter","year":"2016","unstructured":"Kreuter A, Krieg T, Worm M, Wenzel J, Moinzadeh P, Kuhn A, et al. German guidelines for the diagnosis and therapy of localized scleroderma. J Dtsch Dermatol Ges. 2016;14(2):199\u2013216.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"12","key":"1386_CR15","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.3899\/jrheum.081284","volume":"36","author":"T Arkachaisri","year":"2009","unstructured":"Arkachaisri T, Vilaiyuk S, Li S, O'Neil KM, Pope E, Higgins GC, et al. Localized scleroderma clinical and ultrasound study Group.The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures. J Rheumatol. 2009;36(12):2819\u201329.","journal-title":"J Rheumatol"},{"key":"1386_CR16","doi-asserted-by":"crossref","unstructured":"Arkachaisri, T., Vilaiyuk, S., Torok, K.S., Medsger, T.A Jr. (2010). Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study. Rheumatol (Oxford), 49(2), 373\u2013381.","DOI":"10.1093\/rheumatology\/kep361"},{"issue":"1","key":"1386_CR17","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s12955-018-1010-z","volume":"16","author":"A Skrzypek-Salamon","year":"2018","unstructured":"Skrzypek-Salamon A, Lis-\u015awi\u0119ty A, Ranosz-Janicka I, Brzezi\u0144ska-Wcis\u0142o L. Localized scleroderma cutaneous assessment tool (LoSCAT) adapted for use in adult patients: report from an initial validation study. Health Qual Life Outcomes. 2018;16(1):185.","journal-title":"Health Qual Life Outcomes"},{"key":"1386_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5114\/pdia.2014.40654","volume":"31","author":"K Janowski","year":"2014","unstructured":"Janowski K, Steuden S, Bereza B. The polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology. Postepy Dermatol Alergol. 2014;31:12\u201320.","journal-title":"Postepy Dermatol Alergol"},{"issue":"10","key":"1386_CR19","first-page":"1166","volume":"67","author":"J Tylka","year":"2009","unstructured":"Tylka J, Piotrowicz R. Quality of life questionnaire SF-36 -- polish version. Kardiol Pol. 2009;67(10):1166\u20139.","journal-title":"Kardiol Pol"},{"key":"1386_CR20","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/jid.2009.404","volume":"130","author":"CA Prinsen","year":"2010","unstructured":"Prinsen CA, Lindeboom R, Sprangers MA, et al. Health-related quality of life assessment in dermatology: interpretation of Skindex-29 scores using patient-based anchors. J Invest Dermatol. 2010;130:1318\u201322.","journal-title":"J Invest Dermatol"},{"key":"1386_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/jid.2011.138","volume":"131","author":"CA Prinsen","year":"2011","unstructured":"Prinsen CA, Lindeboom R, de Korte J. Interpretation of Skindex-29 scores: cutoffs for mild, moderate, and severe impairment of health-related quality of life. J Invest Dermatol. 2011;131:1945\u20137.","journal-title":"J Invest Dermatol"},{"issue":"12","key":"1386_CR22","first-page":"1302","volume":"67","author":"D Zo\u0142nierczyk-Zreda","year":"2010","unstructured":"Zo\u0142nierczyk-Zreda D. The polish version of the SF-36v2 questionnaire for the quality of life assessment. Przegl Lek. 2010;67(12):1302\u20137.","journal-title":"Przegl Lek"},{"issue":"11","key":"1386_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1477-7525-11-23","volume":"25","author":"M Iudici","year":"2013","unstructured":"Iudici M, Cuomo G, Vettori S, Avellino M, Valentini G. Quality of life as measured by the short-form 36 (SF-36) questionnaire in patients with early systemic sclerosis and undifferentiated connective tissue disease. Health Qual Life Outcomes. 2013;25(11):23.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"1386_CR24","doi-asserted-by":"publisher","first-page":"E756","DOI":"10.3390\/jcm9030756","volume":"9","author":"A Lis-\u015awi\u0119ty","year":"2020","unstructured":"Lis-\u015awi\u0119ty A, Skrzypek-Salamon A, Ranosz-Janicka I, Brzezi\u0144ska-Wcis\u0142o L. Associations between disease activity\/severity and damage and health-related quality of life in adult patients with localized scleroderma-a comparison of LoSCAT and visual analogue scales. J Clin Med. 2020;9(3):E756.","journal-title":"J Clin Med"},{"issue":"2","key":"1386_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jaad.2013.02.007","volume":"69","author":"CE Kelsey","year":"2013","unstructured":"Kelsey CE, Torok KS. The localized scleroderma cutaneous assessment tool: responsiveness to change in a pediatric clinical population. J Am Acad Dermatol. 2013;69(2):214\u201320.","journal-title":"J Am Acad Dermatol"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12955-020-01386-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-020-01386-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T23:49:34Z","timestamp":1620776974000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-020-01386-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,12]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1186\/s12955-020-01386-0","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,12]]},"assertion":[{"value":"14 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"The research was approved by the Medical University of Silesia (ref. KNW\/0022\/KB1\/134\/15).Informed consent: All subject gave written informed consent before their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"133"}}